One receptor can protect antibodies from degradation, extend their half-life and become a drug target itself. Explore the science behind FcRn and how researchers measure its function.
Carterra’s new 48-channel SPR platform reimagines throughput, automation and data quality for modern discovery workflows.
AI is accelerating drug discovery at an unprecedented pace. Thousands of antibody candidates can now be designed in silico within hours. The challenge now is keeping experimental workflows fast enough to keep up. High-throughput expression and integrated developability assessment are making it possible to move from sequence to data in days.
AI is transforming drug discovery - but beyond the hype, what’s actually delivering results? In this expert-led webinar, industry leaders explore where AI is accelerating target identification, molecule design and hit discovery, while also confronting the real-world challenges of data quality, validation and adoption. Discover what’s working today, what still ...
Read storyResearchers often encounter common problems during protein sample preparation which can compromise the quality and quantity of protein obtained. Explore our solutions to these common challenges, including sample handling, storage and preparation method issues.
Here we explore using a mucin-selective protease for tryptic-digest sample preparation of two mucin proteins and assess its potential to improve detecting glycoforms and glycopeptides.
This ebook outlines the basics of fluorescence polarization and discusses the advantages and limitations of FP-based biochemical assays.
This eBook describes different types of assays used to evaluate PARP activity and screening for specific inhibitors.